SPRINT Sprint Bioscience AB (publ)

0.3629USD3.680 SEK · STO-3.16%Mkt Cap: 38.29M USDP/E: 5.26

Sprint Bioscience AB (publ), a pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden. The company develops VPS34, a drug candidate for the treatment of various types of cancer by…